Novel Proteins Regulated by mTOR in Subependymal Giant Cell Astrocytomas of Patients with Tuberous Sclerosis Complex and New Therapeutic Implications
Open Access
- 30 April 2010
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 176 (4), 1878-1890
- https://doi.org/10.2353/ajpath.2010.090950
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Identification of survival‐related genes of the phosphatidylinositol 3′‐kinase signaling pathway in glioblastoma multiformeCancer, 2008
- Possible mechanisms of disease development in tuberous sclerosisThe Lancet Oncology, 2008
- Candidate genes for the progression of malignant gliomas identified by microarray analysisNeurosurgical Review, 2007
- Scaffold mediated regulation of MAPK signaling and cytoskeletal dynamics: A perspectiveCellular Signalling, 2007
- RhoE interferes with Rb inactivation and regulates the proliferation and survival of the U87 human glioblastoma cell lineExperimental Cell Research, 2007
- Small G‐protein RhoE is underexpressed in prostate cancer and induces cell cycle arrest and apoptosisThe Prostate, 2005
- Loss of annexin A1 expression in human breast cancer detected by multiple high-throughput analysesBiochemical and Biophysical Research Communications, 2004
- Rheb is a direct target of the tuberous sclerosis tumour suppressor proteinsNature, 2003
- Biochemical Interactions of the Neuronal PentraxinsPublished by Elsevier BV ,2000
- Calcium-dependent Binding of S100C to the N-terminal Domain of Annexin IPublished by Elsevier BV ,1996